Skip to content

Simultaneous intratympanic dexamethasone and lidocaine injection in patients with otitis media who also have tinnitus

Simultaneous intratympanic administration of lidocaine and dexamethasone for the treatment of tinnitus in patients with sudden sensorineural hearing loss

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251014067616N1
Enrollment
74
Registered
2025-11-25
Start date
2025-10-23
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus in patients with sudden sensory neural hearing loss. Sudden idiopathic hearing loss

Interventions

All participants will receive the standard treatment regimen for sudden sensorineural hearing loss.According to the block randomization list generated by www.sealedenvelope.com, patients will be assig

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and older, sudden sensorineural hearing loss for the first time, onset of unilateral tinnitus with simultaneous onset of sudden hearing loss

Exclusion criteria

Exclusion criteria: Patients with tinnitus due to other acute or chronic causes, a history of sensitivity to lidocaine or dexamethasone, contraindications to lidocaine or dexamethasone, receiving other tinnitus treatments, systemic diseases such as diabetes and hypertension, malignancy, history of head trauma, perforation of the tympanic membrane, and history of ear surgery will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Tinnitus. Timepoint: Before the intervention begins and after the last stage of the intervention. Method of measurement: Audiometry / Tinnitus Handicap Inventory /Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeysam Afrooz

Tehran University of Medical Sciences

afrooz333@gmail.com+98 21 6658 2926

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026